Document is current
Any future updates will be listed below
-
Authors
Holzleitner, Noah
Grünewald, Julian https://orcid.org/0000-0001-7537-7505
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (502106724, 502106724)
- License Information
-
More Information
Article History
First Online: 4 August 2025
Competing interests
: J.G. is a paid consultant for Poseida Therapeutics (recently acquired by Roche Holding), a company developing various gene and cell therapies, and has financial interests in the company. J.G. is a member of the genome editing committee of the American Society of Gene & Cell Therapy (ASGCT) and a board member of the German Society of Gene & Cell Therapy (DGGZT). J.G. is a co-inventor on patent applications filed by Massachusetts General Hospital and the Technical University of Munich (TUM) on various gene editing and cell therapy-related technologies.
